The Pharma Innovation

نویسنده

  • Priya Dahiya
چکیده

Background: Caesarean section is one of the commonest operations performed all over the worlds and its incidence is increasing. As such, there are a number of immediate and delayed complications that may be encountered and the obstetrician must be familiar with and able to rectify these. Hence; we planned the present study to assess the maternal complications associated with cesarean sections. Materials & Subjects: The present study included assessment of women undergoing cesarean sections. A total of 200 cesarean sections were assessed who were admitted to the hospital for delivery. Complete data records of all the subjects along with clinical and demographic details were recorded. Complications occurring in the subjects were recorded by assessing their followup records. All the results were compiled and analysed by SPSS software. Results: 40 percent of the subjects belonged to the age group of 20 to 25 years. Wound infection was the most commonly encountered complication in the present study. Urinary tract infection occurred in 5 percent of the cases. Conclusion: Considerable amount of complications are associated with subjects undergoing cesarean sections. Keyword: Cesarean, Complication, Section

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innovation activities of Big Pharma firms. The study indicates a rising interest of Big Pharma in acquisitions of and alliances with biotechnology companies. Unfortunately, this increased interest is not...

متن کامل

Changing the Model in Pharma and Healthcare - Can We Afford to Wait Any Longer?

Innovation in healthcare delivery and Pharma requires rethinking old problems, retooling with new methodologies and revisiting the process models that are foundations of our existing knowledge discovery and clinical practice. The continuing proliferation of ubiquitous sensor data, mobile devices and the advent of 3D printing of drugs, together with a social mind shift in data ownership are clea...

متن کامل

Recent Trends in Collaborative, Open Source Drug Discovery

The pharmaceutical sector has traditionally played a predominant role in screening compounds against a molecular target and optimizing chemistry to develop drugs. The basic research studies in the academic sector have provided the pharmaceutical companies with many biological targets with potential impact on therapeutics. These welldefined contributions of the pharmaceutical and academic sector...

متن کامل

An Idealized Design For A Networked Change Approach In A Pharmaceutical R&D Organization

Big Pharma is confronted with an unsustainable business model. This is characterized by high attrition rates for medicines under development, increasing regulatory thresholds, and technical complexity of treating diseases of unmet medical need (e.g. Alzheimer’s ). This has driven up the cost of drug development. Pharma companies are using various approaches to stimulate innovation while also ac...

متن کامل

Restructuring and innovation in pharmaceuticals and biotechs: The impact of financialisation

In this paper we explore whether a financialisation perspective can provide a more empirically satisfying account of recent developments in the pharmaceutical industry than the more commonly used resource-based or transaction cost approaches. Specifically, we note the evolution of the pharmaceutical industry structure from giant vertically integrated firms, selling patent protected blockbuster ...

متن کامل

Changing Strategies of Big Pharma

The life sciences are transforming pharmaceutical companies in terms of both internal R&D processes and strategies for external knowledge capture mergers, acquisitions, strategic alliances and licensing. Dr. Mittra’s research on life science innovation and the pharmaceutical industry reveals that these are a cluster of related activities that provide various strategic options for managing innov...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2017